[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Intravenous (IV) Iron Drugs Market Report 2018

February 2018 | 97 pages | ID: UC1C35775BAEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Intravenous (IV) Iron Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Intravenous (IV) Iron Drugs in these regions, from 2013 to 2025 (forecast).
United States Intravenous (IV) Iron Drugs market competition by top manufacturers/players, with Intravenous (IV) Iron Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Sanofi US
  • Allergan
  • AMAG Pharmaceuticals
  • Dalichi Sankyo
  • Luitpold Pharmaceuticals
  • Pharmacosmos
  • Takeda Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Ferric Carboxymaltose
  • Iron Sucrose
  • Iron Dextran
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Nephrology
  • Gynecology & Obstetrics
  • Gastroenterology
  • Oncology
  • Cardiology
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Intravenous (IV) Iron Drugs Market Report 2018

1 INTRAVENOUS (IV) IRON DRUGS OVERVIEW

1.1 Product Overview and Scope of Intravenous (IV) Iron Drugs
1.2 Classification of Intravenous (IV) Iron Drugs by Product Category
  1.2.1 United States Intravenous (IV) Iron Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Intravenous (IV) Iron Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Ferric Carboxymaltose
  1.2.4 Iron Sucrose
  1.2.5 Iron Dextran
  1.2.6 Others
1.3 United States Intravenous (IV) Iron Drugs Market by Application/End Users
  1.3.1 United States Intravenous (IV) Iron Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Nephrology
  1.3.3 Gynecology & Obstetrics
  1.3.4 Gastroenterology
  1.3.5 Oncology
  1.3.6 Cardiology
  1.3.7 Others
1.4 United States Intravenous (IV) Iron Drugs Market by Region
  1.4.1 United States Intravenous (IV) Iron Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Intravenous (IV) Iron Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Intravenous (IV) Iron Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Intravenous (IV) Iron Drugs Status and Prospect (2013-2025)
  1.4.5 New England Intravenous (IV) Iron Drugs Status and Prospect (2013-2025)
  1.4.6 The South Intravenous (IV) Iron Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Intravenous (IV) Iron Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Intravenous (IV) Iron Drugs (2013-2025)
  1.5.1 United States Intravenous (IV) Iron Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Intravenous (IV) Iron Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES INTRAVENOUS (IV) IRON DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Intravenous (IV) Iron Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Intravenous (IV) Iron Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Intravenous (IV) Iron Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Intravenous (IV) Iron Drugs Market Competitive Situation and Trends
  2.4.1 United States Intravenous (IV) Iron Drugs Market Concentration Rate
  2.4.2 United States Intravenous (IV) Iron Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Intravenous (IV) Iron Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INTRAVENOUS (IV) IRON DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Intravenous (IV) Iron Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Intravenous (IV) Iron Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Intravenous (IV) Iron Drugs Price by Region (2013-2018)

4 UNITED STATES INTRAVENOUS (IV) IRON DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Intravenous (IV) Iron Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Intravenous (IV) Iron Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Intravenous (IV) Iron Drugs Price by Type (2013-2018)
4.4 United States Intravenous (IV) Iron Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES INTRAVENOUS (IV) IRON DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Intravenous (IV) Iron Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Intravenous (IV) Iron Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES INTRAVENOUS (IV) IRON DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi US
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Intravenous (IV) Iron Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi US Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Allergan
  6.2.2 Intravenous (IV) Iron Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergan Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 AMAG Pharmaceuticals
  6.3.2 Intravenous (IV) Iron Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Dalichi Sankyo
  6.4.2 Intravenous (IV) Iron Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Luitpold Pharmaceuticals
  6.5.2 Intravenous (IV) Iron Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Pharmacosmos
  6.6.2 Intravenous (IV) Iron Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Takeda Pharmaceutical
  6.7.2 Intravenous (IV) Iron Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview

7 INTRAVENOUS (IV) IRON DRUGS MANUFACTURING COST ANALYSIS

7.1 Intravenous (IV) Iron Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Intravenous (IV) Iron Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INTRAVENOUS (IV) IRON DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Intravenous (IV) Iron Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Intravenous (IV) Iron Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Intravenous (IV) Iron Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Intravenous (IV) Iron Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Intravenous (IV) Iron Drugs
Figure United States Intravenous (IV) Iron Drugs Market Size (K Units) by Type (2013-2025)
Figure United States Intravenous (IV) Iron Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Ferric Carboxymaltose Product Picture
Figure Iron Sucrose Product Picture
Figure Iron Dextran Product Picture
Figure Others Product Picture
Figure United States Intravenous (IV) Iron Drugs Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Intravenous (IV) Iron Drugs by Application in 2017
Figure Nephrology Examples
Table Key Downstream Customer in Nephrology
Figure Gynecology & Obstetrics Examples
Table Key Downstream Customer in Gynecology & Obstetrics
Figure Gastroenterology Examples
Table Key Downstream Customer in Gastroenterology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Intravenous (IV) Iron Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Intravenous (IV) Iron Drugs Sales (K Units) and Growth Rate (2013-2025)
Figure United States Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Intravenous (IV) Iron Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Intravenous (IV) Iron Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Intravenous (IV) Iron Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Intravenous (IV) Iron Drugs Sales Share by Players/Suppliers
Figure 2017 United States Intravenous (IV) Iron Drugs Sales Share by Players/Suppliers
Figure United States Intravenous (IV) Iron Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Intravenous (IV) Iron Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Intravenous (IV) Iron Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Intravenous (IV) Iron Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Intravenous (IV) Iron Drugs Revenue Share by Players/Suppliers
Table United States Market Intravenous (IV) Iron Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Intravenous (IV) Iron Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Intravenous (IV) Iron Drugs Market Share of Top 3 Players/Suppliers
Figure United States Intravenous (IV) Iron Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Intravenous (IV) Iron Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Intravenous (IV) Iron Drugs Product Category
Table United States Intravenous (IV) Iron Drugs Sales (K Units) by Region (2013-2018)
Table United States Intravenous (IV) Iron Drugs Sales Share by Region (2013-2018)
Figure United States Intravenous (IV) Iron Drugs Sales Share by Region (2013-2018)
Figure United States Intravenous (IV) Iron Drugs Sales Market Share by Region in 2017
Table United States Intravenous (IV) Iron Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Intravenous (IV) Iron Drugs Revenue Share by Region (2013-2018)
Figure United States Intravenous (IV) Iron Drugs Revenue Market Share by Region (2013-2018)
Figure United States Intravenous (IV) Iron Drugs Revenue Market Share by Region in 2017
Table United States Intravenous (IV) Iron Drugs Price (USD/Unit) by Region (2013-2018)
Table United States Intravenous (IV) Iron Drugs Sales (K Units) by Type (2013-2018)
Table United States Intravenous (IV) Iron Drugs Sales Share by Type (2013-2018)
Figure United States Intravenous (IV) Iron Drugs Sales Share by Type (2013-2018)
Figure United States Intravenous (IV) Iron Drugs Sales Market Share by Type in 2017
Table United States Intravenous (IV) Iron Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Intravenous (IV) Iron Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Intravenous (IV) Iron Drugs by Type (2013-2018)
Figure Revenue Market Share of Intravenous (IV) Iron Drugs by Type in 2017
Table United States Intravenous (IV) Iron Drugs Price (USD/Unit) by Types (2013-2018)
Figure United States Intravenous (IV) Iron Drugs Sales Growth Rate by Type (2013-2018)
Table United States Intravenous (IV) Iron Drugs Sales (K Units) by Application (2013-2018)
Table United States Intravenous (IV) Iron Drugs Sales Market Share by Application (2013-2018)
Figure United States Intravenous (IV) Iron Drugs Sales Market Share by Application (2013-2018)
Figure United States Intravenous (IV) Iron Drugs Sales Market Share by Application in 2017
Table United States Intravenous (IV) Iron Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Intravenous (IV) Iron Drugs Sales Growth Rate by Application (2013-2018)
Table Sanofi US Basic Information List
Table Sanofi US Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi US Intravenous (IV) Iron Drugs Sales Growth Rate (2013-2018)
Figure Sanofi US Intravenous (IV) Iron Drugs Sales Market Share in United States (2013-2018)
Figure Sanofi US Intravenous (IV) Iron Drugs Revenue Market Share in United States (2013-2018)
Table Allergan Basic Information List
Table Allergan Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan Intravenous (IV) Iron Drugs Sales Growth Rate (2013-2018)
Figure Allergan Intravenous (IV) Iron Drugs Sales Market Share in United States (2013-2018)
Figure Allergan Intravenous (IV) Iron Drugs Revenue Market Share in United States (2013-2018)
Table AMAG Pharmaceuticals Basic Information List
Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales Growth Rate (2013-2018)
Figure AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales Market Share in United States (2013-2018)
Figure AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Revenue Market Share in United States (2013-2018)
Table Dalichi Sankyo Basic Information List
Table Dalichi Sankyo Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dalichi Sankyo Intravenous (IV) Iron Drugs Sales Growth Rate (2013-2018)
Figure Dalichi Sankyo Intravenous (IV) Iron Drugs Sales Market Share in United States (2013-2018)
Figure Dalichi Sankyo Intravenous (IV) Iron Drugs Revenue Market Share in United States (2013-2018)
Table Luitpold Pharmaceuticals Basic Information List
Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales Growth Rate (2013-2018)
Figure Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales Market Share in United States (2013-2018)
Figure Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Revenue Market Share in United States (2013-2018)
Table Pharmacosmos Basic Information List
Table Pharmacosmos Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pharmacosmos Intravenous (IV) Iron Drugs Sales Growth Rate (2013-2018)
Figure Pharmacosmos Intravenous (IV) Iron Drugs Sales Market Share in United States (2013-2018)
Figure Pharmacosmos Intravenous (IV) Iron Drugs Revenue Market Share in United States (2013-2018)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales Market Share in United States (2013-2018)
Figure Takeda Pharmaceutical Intravenous (IV) Iron Drugs Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous (IV) Iron Drugs
Figure Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
Figure Intravenous (IV) Iron Drugs Industrial Chain Analysis
Table Raw Materials Sources of Intravenous (IV) Iron Drugs Major Players/Suppliers in 2017
Table Major Buyers of Intravenous (IV) Iron Drugs
Table Distributors/Traders List
Figure United States Intravenous (IV) Iron Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Intravenous (IV) Iron Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Intravenous (IV) Iron Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Intravenous (IV) Iron Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Intravenous (IV) Iron Drugs Sales Volume (K Units) Forecast by Type in 2025
Table United States Intravenous (IV) Iron Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Intravenous (IV) Iron Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Intravenous (IV) Iron Drugs Sales Volume (K Units) Forecast by Application in 2025
Table United States Intravenous (IV) Iron Drugs Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Intravenous (IV) Iron Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Intravenous (IV) Iron Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Intravenous (IV) Iron Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories